These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 9373320

  • 1. Epitope mapping of a C5a neutralizing mAb using a combined approach of phage display, synthetic peptides and site-directed mutagenesis.
    Kola A, Baensch M, Bautsch W, Hennecke M, Klos A, Casaretto M, Köhl J.
    Immunotechnology; 1996 Jun; 2(2):115-26. PubMed ID: 9373320
    [Abstract] [Full Text] [Related]

  • 2. Stabilization of an isolated helical capping box in solution by hydrophobic interactions: evidence from the NMR study of bioactive peptides from the C-terminus of human C5a anaphylatoxin.
    Ni F, Carpenter KA, Ripoll DR, Sanderson SD, Hugli TE.
    Biopolymers; 1996 Jan; 38(1):31-41. PubMed ID: 8679942
    [Abstract] [Full Text] [Related]

  • 3. A detailed analysis of the C5a anaphylatoxin effector domain: selection of C5a phage libraries on differentiated U937 cells.
    Hennecke M, Otto A, Baensch M, Kola A, Bautsch W, Klos A, Köhl J.
    Eur J Biochem; 1998 Feb 15; 252(1):36-44. PubMed ID: 9523709
    [Abstract] [Full Text] [Related]

  • 4. Mutation of glutamate 199 of the human C5a receptor defines a binding site for ligand distinct from the receptor N terminus.
    Monk PN, Barker MD, Partridge LJ, Pease JE.
    J Biol Chem; 1995 Jul 14; 270(28):16625-9. PubMed ID: 7622471
    [Abstract] [Full Text] [Related]

  • 5. A selection system to study C5a-C5a-receptor interactions: phage display of a novel C5a anaphylatoxin, Fos-C5aAla27.
    Hennecke M, Kola A, Baensch M, Wrede A, Klos A, Bautsch W, Köhl J.
    Gene; 1997 Jan 15; 184(2):263-72. PubMed ID: 9031638
    [Abstract] [Full Text] [Related]

  • 6. Analysis of the C5a anaphylatoxin core domain using a C5a phage library selected on differentiated U937 cells.
    Kola A, Baensch M, Bautsch W, Klos A, Köhl J.
    Mol Immunol; 1999 Feb 15; 36(2):145-52. PubMed ID: 10378686
    [Abstract] [Full Text] [Related]

  • 7. Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor. Arg2O6 determines high-affinity binding sites of C5a receptor.
    Raffetseder U, Röper D, Mery L, Gietz C, Klos A, Grötzinger J, Wollmer A, Boulay F, Köhl J, Bautsch W.
    Eur J Biochem; 1996 Jan 15; 235(1-2):82-90. PubMed ID: 8631370
    [Abstract] [Full Text] [Related]

  • 8. Site-specific mutagenesis of residues in the human C5a anaphylatoxin which are involved in possible interaction with the C5a receptor.
    Bubeck P, Grötzinger J, Winkler M, Köhl J, Wollmer A, Klos A, Bautsch W.
    Eur J Biochem; 1994 Feb 01; 219(3):897-904. PubMed ID: 8112341
    [Abstract] [Full Text] [Related]

  • 9. Selection of novel ligands from a whole-molecule randomly mutated C5a library.
    Cain SA, Williams DM, Harris V, Monk PN.
    Protein Eng; 2001 Mar 01; 14(3):189-93. PubMed ID: 11342716
    [Abstract] [Full Text] [Related]

  • 10. Interference by anti-C5a monoclonal antibodies with the binding of C5a to cellular receptors and the induction of enzyme release from granulocytes.
    Bergh K, Iversen OJ.
    Complement Inflamm; 1991 Mar 01; 8(5-6):294-302. PubMed ID: 1802548
    [Abstract] [Full Text] [Related]

  • 11. Monoclonal antibody screening of a phage-displayed random peptide library reveals mimotopes of chemokine receptor CCR5: implications for the tertiary structure of the receptor and for an N-terminal binding site for HIV-1 gp120.
    Königs C, Rowley MJ, Thompson P, Myers MA, Scealy M, Davies JM, Wu L, Dietrich U, Mackay CR, Mackay IR.
    Eur J Immunol; 2000 Apr 01; 30(4):1162-71. PubMed ID: 10760806
    [Abstract] [Full Text] [Related]

  • 12. Solution structure of a unique C5a semi-synthetic antagonist: implications in receptor binding.
    Zhang X, Boyar W, Galakatos N, Gonnella NC.
    Protein Sci; 1997 Jan 01; 6(1):65-72. PubMed ID: 9007977
    [Abstract] [Full Text] [Related]

  • 13. Identification of a dengue virus type 2 (DEN-2) serotype-specific B-cell epitope and detection of DEN-2-immunized animal serum samples using an epitope-based peptide antigen.
    Wu HC, Jung MY, Chiu CY, Chao TT, Lai SC, Jan JT, Shaio MF.
    J Gen Virol; 2003 Oct 01; 84(Pt 10):2771-2779. PubMed ID: 13679612
    [Abstract] [Full Text] [Related]

  • 14. Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.
    Wong AK, Finch AM, Pierens GK, Craik DJ, Taylor SM, Fairlie DP.
    J Med Chem; 1998 Aug 27; 41(18):3417-25. PubMed ID: 9719594
    [Abstract] [Full Text] [Related]

  • 15. Antagonistic peptides against human anaphylatoxin C5a.
    Kaneko Y, Okada N, Baranyi L, Azuma T, Okada H.
    Immunology; 1995 Sep 27; 86(1):149-54. PubMed ID: 7590876
    [Abstract] [Full Text] [Related]

  • 16. Fine epitope mapping of monoclonal antibody 5F1 reveals anticatalytic activity toward the N domain of human angiotensin-converting enzyme.
    Danilov SM, Watermeyer JM, Balyasnikova IV, Gordon K, Kugaevskaya EV, Elisseeva YE, Albrecht RF, Sturrock ED.
    Biochemistry; 2007 Aug 07; 46(31):9019-31. PubMed ID: 17630779
    [Abstract] [Full Text] [Related]

  • 17. Effective suppression of C5a-induced proinflammatory response using anti-human C5a repebody.
    Hwang DE, Choi JM, Yang CS, Lee JJ, Heu W, Jo EK, Kim HS.
    Biochem Biophys Res Commun; 2016 Sep 02; 477(4):1072-1077. PubMed ID: 27416759
    [Abstract] [Full Text] [Related]

  • 18. Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury.
    Heller T, Hennecke M, Baumann U, Gessner JE, zu Vilsendorf AM, Baensch M, Boulay F, Kola A, Klos A, Bautsch W, Köhl J.
    J Immunol; 1999 Jul 15; 163(2):985-94. PubMed ID: 10395696
    [Abstract] [Full Text] [Related]

  • 19. Identification of the human melanoma-associated chondroitin sulfate proteoglycan antigen epitope recognized by the antitumor monoclonal antibody 763.74 from a peptide phage library.
    Geiser M, Schultz D, Le Cardinal A, Voshol H, García-Echeverría C.
    Cancer Res; 1999 Feb 15; 59(4):905-10. PubMed ID: 10029083
    [Abstract] [Full Text] [Related]

  • 20. Receptor activation by human C5a des Arg74 but not intact C5a is dependent on an interaction between Glu199 of the receptor and Lys68 of the ligand.
    Crass T, Bautsch W, Cain SA, Pease JE, Monk PN.
    Biochemistry; 1999 Jul 27; 38(30):9712-7. PubMed ID: 10423250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.